Why the study?
It was largely unknown how and to what extent cellular host factors alter the mechanical properties of viral frameshift elements to impact SARS-CoV-2 virulence.
ZAP-S acts as a host-encoded inhibitor of SARS-CoV-2 frameshifting, reducing viral replication and highlighting a potential target for RNA-based antiviral strategies.
Answers are grounded in this paper and cite their sources.
ZAP-S may represent a host antiviral factor; leaves open whether it can be harnessed for RNA-based SARS-CoV-2 therapies in humans.
Programmed ribosomal frameshifting (PRF) is a fundamental gene expression event in many viruses, including SARS-CoV-2. It allows production of essential viral, structural and replicative enzymes that are encoded in an alternative reading frame. Despite the importance of PRF for the viral life cycle, it is still largely unknown how and to what extent cellular factors alter mechanical properties of frameshift elements and thereby impact virulence. This prompted us to comprehensively dissect the interplay between the SARS-CoV-2 frameshift element and the host proteome. We reveal that the short isoform of the zinc-finger antiviral protein (ZAP-S) is a direct regulator of PRF in SARS-CoV-2 infected cells. ZAP-S overexpression strongly impairs frameshifting and inhibits viral replication. Using in vitro ensemble and single-molecule techniques, we further demonstrate that ZAP-S directly interacts with the SARS-CoV-2 RNA and interferes with the folding of the frameshift RNA element. Together, these data identify ZAP-S as a host-encoded inhibitor of SARS-CoV-2 frameshifting and expand our understanding of RNA-based gene regulation.
No takes yet. Share an insight, caveat, or question.
Zimmer et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: